Skip to main content
lexblog.com/lib/RS099Z08viewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "FDA Issues New Guidance on Biosimilar Development under the BPCIA",
    "url": "https://www.lexblog.com/2019/01/11/fda-issues-new-guidance-on-biosimilar-development-under-the-bpcia/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-RS099Z08",
        "url": "https://www.lexblog.com/lib/RS099Z08/"
    },
    "datePublished": "2019-01-11T17:00:50-05:00",
    "dateModified": "2021-11-08T10:14:55-05:00",
    "author": {
        "@type": "Person",
        "name": "Caitlin M. Wilmot"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "http://www.biosimilarsip.com/?p=4761",
    "sourceStability": "may-move"
}